EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Genome-engineering technologies for modeling and treatment of cystic fibrosis

Michał Dębczyński, Damian Mojsak, Łukasz Minarowski, Monika Maciejewska, Paweł Lisowski, Robert M Mróz

Advances in Medical Sciences · 2023

DOI: 10.1016/j.advms.2023.02.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Medical Sciences, 2023. Verfasst von Michał Dębczyński und 5 weiteren Autor:innen. Beteiligte Einrichtung: II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland. Electronic address: michal.debczynski@umb.edu.pl. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is an autosomal recessive disease caused by defects in the CF transmembrane conductance regulator (CFTR) protein. Due to the genetic nature of the disease, interventions in the genome can target any underlying alterations and potentially provide permanent disease resolution. The current development of gene-editing tools, such as designer nuclease technology capable of genome correction, holds great promise for both CF and other genetic diseases. In recent years, Cas9-based technologies have enabled the generation of genetically defined human stem cell and disease models based on induced pluripotent stem cells (iPSC). In this article, we outline the potential and possibilities of using CRISPR/Cas9-based gene-editing technology in CF modeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisHumansGene EditingTechnology

Stichwörter der Autor:innen

CRISPRCystic fibrosisPrime editingStem cell-based disease modelinghiPSC

Autor:innen und Institutionen

  • II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland. Electronic address: michal.debczynski@umb.edu.pl.
  • II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland.
  • II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland; Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Magdalenka, Poland; Department of Psychiat…

Förderung

  • Medical University of Bialystok

Zitieren

APA

Dębczyński, M., Mojsak, D., Minarowski, Ł., Maciejewska, M., Lisowski, P., & Mróz, R. M. (2023). Genome-engineering technologies for modeling and treatment of cystic fibrosis. Advances in Medical Sciences. https://doi.org/10.1016/j.advms.2023.02.003

Vancouver

Dębczyński M, Mojsak D, Minarowski Ł, Maciejewska M, Lisowski P, Mróz RM. Genome-engineering technologies for modeling and treatment of cystic fibrosis. Advances in Medical Sciences. 2023. doi:10.1016/j.advms.2023.02.003

BibTeX
@article{Dbczyski2023,
  author = {Dębczyński, Michał and Mojsak, Damian and Minarowski, Łukasz and Maciejewska, Monika and Lisowski, Paweł and Mróz, Robert M},
  title = {Genome-engineering technologies for modeling and treatment of cystic fibrosis},
  journal = {Advances in Medical Sciences},
  year = {2023},
  doi = {10.1016/j.advms.2023.02.003}
}
Kostenlos starten →